Background: T cells and B cells communicate by direct cell-cell interaction that is crucial to the functioning of the immune system. It is well established that the interaction between B-cell-expressed CD40 and T-cell-expressed CD40 ligand (CD40L) is critical for T-cell-dependent antibody responses, but the role of this interaction in T-cell responses is less clear. In this study, we have used mice with targeted mutations in the genes encoding CD40L or CD28 to investigate how the CD40-CD40L interaction induces on B cells a costimulatory activity that acts in addition to antigen to trigger T-cell growth. Results: We show that T cells from CD40L-deficient mice induce a substantially reduced costimulatory activity on B cells compared to wild-type T cells, particularly at early time points. Surprisingly, T cells from CD40L-deficient mice induce similar levels of B7-1 and B7-2 as do wild-type T cells. We further show that the CD40L-mediated induction of costimulatory activity precedes the induction of B7-1, B7-2 and the heat-stable antigen (HSA). CD4 T cells isolated from the CD28-deficient mice can receive costimulatory activity from CD40L-induced B cells, demonstrating that the induced molecules can costimulate T cells by a CD28-independent mechanism. We have generated a novel monoclonal antibody that inhibits the CD40L-induced costimulatory activity. Expression of the epitope detected by this monoclonal antibody correlates with the induction of the costimulatory activity, and the molecule recognized by the monoclonal antibody is a single chain of around 85 kDa, distinct from B7-1, B7-2, ICAM-1, ICAM-2, ICAM-3, HSA, CD5, integrin and 4-1BB ligand.
Background
The interaction between T cells and B cells is the prototypical example of cell-cell interaction in the immune system. The basis for the specificity of this interaction was established 10 years ago by the elegant study of Lanzavecchia [1] , which showed that the interaction of antigen with the B-cell surface immunoglobulin allows specific antigen uptake, processing and presentation -to T cells -of an antigenic peptide in association with class II major histocompatibility complex (MHC) molecules. It was assumed that the T cells that recognize the MHC-bound antigen would then be activated and deliver the 'help' to B cells that is required for a robust antibody response [2] .
Recent studies have shown, however, that T-cell activation requires two types of biological signal: one delivered by engagement of the T-cell receptor (TCR), which determines the specificity of T-cell activation, and the other delivered by a 'costimulatory' pathway, which determines the fate of T cells [3] [4] [5] [6] [7] [8] [9] [10] [11] . Several costimulatory molecules, such as B7-1, B7-2 and the heat-stable antigen (HSA), have been shown to be involved in promoting T-cell clonal expansion and preventing T-cell inactivation following TCR engagement [12] [13] [14] [15] . These three costimulatory molecules are expressed either constitutively or inducibly on B cells [12] [13] [14] [15] [16] [17] [18] [19] . Because of the active role of B cells in T-cell responses, we and others have proposed that immunological help is delivered reciprocally between T and B cells [19] [20] [21] [22] .
The interaction between B cells and T cells mediated by B-cell-expressed CD40 and T-cell-expressed CD40 ligand (CD40L) is necessary for T cells to deliver help to cognate B cells. Several groups have shown that mutations in the gene encoding CD40L are responsible for the Xlinked hyper-immunoglobulin M (IgM) syndrome in human patients [23] [24] [25] [26] . In mice, it has been demonstrated that the CD40-CD40L interaction can be blocked by an anti-CD40L monoclonal antibody [27] , or by soluble CD40L fusion protein [28] ; more recently, mice with a targeted mutation of the CD40L gene have been generated [29] . Disruption of the CD40-CD40L interaction in these ways leads to a profound deficiency in the formation of germinal centers, the generation of memory antibody responses, and antibody class switching.
Three pieces of evidence strongly suggest that this pathway is also responsible for induction of the costimulatory activity required for T-cell growth. Firstly, an antibody directed Correspondence to: Yang Liu and Richard A. Flavell (who contributed equally to this work).
against CD40L has been shown to inhibit the activation of transgenic T cells [22] . Secondly, antibodies directed against CD40L [22] or CD40 [30] inhibit the induction by T cells of B7-1 and B7-2, two important costimulatory molecules for T-cell activation. Thirdly, recombinant CD40L has been shown to induce a CTLA4 ligand on B cells -most likely B7-1 or B7-2 [19] . These findings indicate that the CD40-CD40L interaction switches on costimulatory activity on B cells by inducing expression of B7. However, the inhibition of the T-cell response by an antibody could be due to a negative signaling mechanism. More importantly, these three studies evaluated the induced costimulatory molecules after 24-48 hours of CD40L-CD40 engagement. As the consequences of TCR engagement are determined within 6 hours [31, 32] , the physiological significance of such costimulatory activity induced after 24 hours of CD40L-CD40 interaction is questionable.
We have recently generated mice with a targeted mutation in the gene encoding CD40L [29] . In order to avoid the two major caveats mentioned above, we have used these mice to examine the importance and nature of the costimulatory activity that is induced by the CD40L-CD40 interaction. Our results demonstrate that CD40L rapidly induces a novel costimulatory activity that is distinct from B7-1, B7-2 and HSA, and that is independent of CD28.
Results

CD40L is essential for the optimal induction of costimulatory activity on antigen-presenting cells
Our recent studies have indicated that, in the presence of anti-CD3 antibody, CD4 T cells induce the expression of costimulatory activity on syngeneic antigen-presenting cells (APCs) [16, 33] . Using gene-targeted B-celldeficient mice, we showed that, in this model, all of the costimulatory activity induced by T cells is expressed on B cells [34] . In order to analyze whether the CD40-CD40L interaction is required for this induction of costimulatory activity, we used the immune cells of gene-targeted CD40L-deficient mice. Briefly, spleen cells were stimulated for a given period and then depleted ofT cells. The viable APCs were fixed with paraformaldehyde and their fixation-resistant costimulatory activity determined by measuring the proliferation of purified CD4 T cells in response to an anti-CD3 antibody. Fixation of the APCs prevents further induction of costimulatory activity by the T cells.
Upon stimulation with the anti-CD3 antibody, significant costimulatory activity was induced on T-depleted spleen cells from wild-type littermates (Fig. la) . However, a six-to nine-fold reduction in costimulatory activity was observed when the spleen cells from CD40L-deficient mice were used (Fig. la) . The optimal induction of costimulatory activity also required cell-cell contact, as T-depleted spleen cells placed in a chamber and separated from anti-CD3-stimulated spleen cells by a 0.2 .Lm membrane at the induction phase had a much lower level of costimulatory activity (Fig. lb) .
In order to test whether the reduced induction of costimulatory activity was due to a defect in the T cells, CD4 T cells from either wild-type or CD40L-deficient mice were mixed with T-depleted spleen cells from either strain of mice in the induction phase. The mixture was then depleted of T cells and the costimulatory activity on the APCs was determined. As shown in regardless of the source of T-depleted spleen cells, T cells from wild-type mice could induce costimulatory activity, whereas T cells from CD40L-deficient mice induced only low levels of activity. These results indicate that the defects caused by targeted mutation of the CD40L gene are due to malfunction of the T cells.
CD40L is not required for T-cell-mediated induction of B7-2
We have shown previously that CD4 T cells induce B7-2 expression on B cells [33] ; we therefore tested whether the differential induction of costimulatory activity by T cells from wild-type and CD40L-deficient mice was due to the differential induction of B7-2. Surprisingly, a comparable level of B7-2 was induced by either source of T cells (Fig. 2a-d ). Similar levels of B7-2 were induced when the T-depleted spleen cells were separated from T cells; thus, the induction of B7-2 is contact-independent. B7-2 expressed on APCs, induced by T cells from wildtype or CD40L-deficient mice, was immunoprecipitated with the anti-B7-2 monoclonal antibody GL-1; both immunoprecipitates showed a similar molecular weight (Fig. 2e) . It is therefore unlikely that the glycosylation of B7-2 is affected by the CD40L on T cells.
We also compared the kinetics of induction of costimulatory activity with that of B7-2 in both wild-type and CD40L-deficient mice. As shown in Figure 3 , the kinetics of B7-2 induction were similar whether wild-type or CD40L-deficient spleen cells were used. As we have shown with other strains of mice, HSA was constitutively expressed and B7-1 was undetectable during the period studied. However, the induction of costimulatory activity was significantly slower in the CD40L-deficient spleen cells. Furthermore, the optimal costimulatory activity induced by CD40L-deficient T cells was about ten-fold less than that induced by wild-type T cells.
CD40L-mediated induction of costimulatory activity on
APCs precedes the induction of B7-1/B7-2 A logical, although perhaps unexpected, conclusion from the above results is that the costimulatory molecules that are rapidly induced by CD40L are distinct from B7-1, B7-2 and HSA. In order to test this hypothesis directly, we used COS cells that were transfected with the CD40L gene to induce costimulatory activity on T-depleted Aa
Time (hours after stimulation) 5 15 25 Fig . 3 . Kinetics of induction of (a) costimulatory activity and of (b) the costimulatory molecules B7-2, B7-1 and HSA, in wildtype and CD40L-deficient mice. Spleen cells from CD40L-deficient and wild-type mice were stimulated for different times, T cells were then depleted, and the costimulatory activity determined as described in the legend to Figure 1 . The expression of the costimulatory molecules was determined by flow cytometry using anti-B7-2 mAb GL-1, anti-HSA mAb M1/69, anti-B7-1 mAbs (a mixture of 1D5, 3A12, and 7A5). The data shown are mean fluorescence, with background fluorescence (second-step reagents only) subtracted. The expression of B7-1 in both CD40L-deficient and wild-type spleen cells was not detectable at any of the time points tested (< 0), and an artificial number was used throughout. spleen cells, using mock-transfected cells as a control. We then compared the kinetics of the induced expression of costimulatory activity with those of the three known costimulatory molecules, B7-1, B7-2 and HSA. As shown in Figure 4a , costimulatory activity was induced as early as within 3 hours of co-culture of T-depleted spleen cells with the CD40L-transfected COS cells. The costimulatory activity increased and peaked after 24 hours of co-culture. No significant costimulatory activity was induced by the mock-transfected COS cells. The anti-CD40L monoclonal antibody MR1 completely blocked this induction of costimulatory activity (data not shown).
There was no correlation between the induction of the costimulatory activity and that of the three costimulatory molecules studied previously (Fig. 4b ). B7-2 was expressed at equal levels on APCs cultured with either mock-transfected or CD40L-transfected COS cells at 3 hours and 6 hours of co-culture. At 12 hours, an increased expression of B7-2 was detected on APCs that were cultured with CD40L-transfected COS cells. The level of B7-2 increased steadily on APCs co-cultured with CD40L-transfected COS cells, but remained constant on APCs co-cultured with mock-transfected COS cells. The expression of B7-1 was either not observed, or was at a very low level starting at 24 hours of co-culture (data not shown). A decrease in the levels of HSA was observed, although a significant amount of the HSA was always expressed on the majority of the T-depleted spleen cells. The lack of correlation between the induction of B7-2 and the costimulatory activity was not due to the sensitivity of our fluorescence-activated cell sorter (FACS) analysis, as a low but significant expression of B7-2 could be detected on uncultured APCs and on APCs co-cultured with the mock-transfected COS cells, which had no detectable costimulatory activity.
CD40L-induced activity costimulates proliferation of T cells from CD28-deficient mice
In order to test whether the costilmulatory activity that was distinct from B7-1, B7-2 and HSA depended for its action on the expression by T cells of CD28, we tested whether T cells from mice with a targeted mutation in the CD28 gene could respond to CD40L-induced B cells. As shown in Figure 5 , CD40L-stimulated B cells had potent costimulatory activity for CD28-deficient T cells. In contrast, control B cells failed to costimulate such T cells. At least part of the costimulatory activity induced by CD40L is therefore independent of CD28. 
Characterization of a monoclonal antibody which inhibits CD40L-induced costimulatory activity
As a first step towards identifying the novel costimulatory molecule(s) induced on B cells by CD40L, we immunized hamsters with CD40L-stimulated B cells, generated mouse-hamster hybridomas and screened for monoclonal antibodies that could bind the costimulatory molecule(s). Out of 2 400 hybridomas generated, we
Time after culture (hours) The expression of the costimulatory molecules B7-2, B7-1 and HSA on APCs. Viable APCs were stained with mAbs and secondstep reagents, and the expression of the costimulatory molecules was determined by flow cytometry as described in the legend to Fig. 3 . Data shown are the mean fluorescence of the samples stained with a specific mAb; the background staining (fluorescence in the presence of the second-step reagent alone) was always below 20 and has been subtracted. The data are representative of three independent experiments. The apparently significant costimulatory activity of B cells stimulated by mocktransfected COS cells for 6 h in (a) was not reproducible, and was probably due to inadequate fixation of B cells. obtained one stable hybridoma that secreted a monoclonal antibody (TM-1) specific to a CD40L-induced costimulatory activity. As shown in Figure 6a , TM-1 significantly inhibited the costimulatory activity induced by CD40L; the control hamster IgG monoclonal antibody 3H12 did not inhibit this activity.
The induction of TM-1-epitope expression correlated with the induction of costimulatory activity. As shown in Figure 6b , B cells cultured for 4 hours with CD40L-transfected fibroblasts had potent costimulatory activity for CD4 T-cell proliferation; this activity increased until 16 hours of stimulation. Untransfected fibroblasts did not induce costimulatory activity on B cells. Correspondingly, B cells cultured with CD40L-transfected fibroblasts expressed a significantly higher level of TM-1 epitope at 4 hours than those cultured with untransfected fibroblasts (Fig. 6c) . The difference in expression levels increased until 16 hours of culture. However, these two populations of B cells expressed equal levels of B7-2 at 4 hours and 8 hours of culture, although a significant induction of B7-2 was observed at 16 hours of stimulation. These results reaffirm the lack of correlation between the induction of B7-2 and the existence of costimulatory activity.
The TM-1 monoclonal antibody bound a single molecule of-85 kDa (Fig. 7a) . Flow cytometry analysis indicated that TM-1 does not bind B7-1, B7-2 or ICAM-1 (Fig. 7b) . The molecular wight of molecule that TM-1 recognizes also precludes the possibility that TM-1 binds other cell-surface molecules that are implicated in T cell costimulation, such as ICAM-2, ICAM-3, integrins, CD5 or 4-1BB ligand.
Discussion
Numerous studies have demonstrated that the interaction between CD40 and CD40L is critical for immunological help from T cells to B cells [23] [24] [25] [26] [27] [28] [29] . The role of this interaction in T-cell activation is less clear. Although previous studies [19, 23, 30] indicate that the CD40L-CD40 interaction plays a critical role in the T-cell-mediated induction of costimulatory activity on APCs, these experiments have two major caveats. Firstly, the conclusion is based on antibody-inhibition data, which could be due to negative signaling rather than blocking. Secondly, and more importantly, the expression of costimulatory activity and costimulatory molecules was measured 24-48 hours after TCR engagement. Costimulatory activity is required within 6 hours of TCR engagement in order to prevent clonal anergy of T cells [31, 32] ; it is therefore questionable whether the expression of costimulatory molecules measured in these previous studies is relevant.
In this study, we have used mice with targeted mutations in the genes encoding CD40L or CD28 to test the role of this interaction in T-cell mediated induction of costimulatory activity on B cells. We show that there is a significant induction of costimulatory activity within 2 hours of TCR engagement, and that T cells from wild-type mice induce a significantly more rapid and more potent costimulatory activity on APCs. Using COS cells transfected with the CD40L gene, we demonstrate that the induction of costimulatory activity by CD40L can be very rapid, and occurs within 3 hours of CD40 engagement. These results demonstrate unequivocally that CD40L is necessary and sufficient for optimal induction by T cells of costimulatory activity on the APCs. The rapid kinetics of this induction suggest that CD40L-mediated induction is likely that a cytokine(s) can also up-regulate B7-2 on of costimulatory activity may be involved in preventing
APCs, as has been demonstrated by Hathcock et al. [36] . inactivation ofT cells following TCR engagement.
It is possible that in the transgenic model used by Foy et al. [22] , the particular CD4 T cells may lack the ability to A critical issue is the identity of the costimulatory molemake this cytokine(s).
cules that are rapidly induced by CD40L-CD40 interaction. Although Foy et al. [22] suggested that CD40L is critical for B7-2 induction, we have found that the Tcell-mediated induction of B7-2 is unaffected by targeted mutation of the CD40L gene. Because the induction of
The simplest hypothesis to explain our observationsthat T cells from CD40L-deficient mice and wild-type littermates induce equal levels of B7-2 but different levels of costimulatory activity on APCs -is that CD40L can B7-2 by T cells is contact-independent in our model, it induce other costimulatory molecules. In order to test for 16 h were cell-surfacelabeled with 1251, and lysed as described [42] . Immunoprecipitation was carried out using either a control mAb (hamster anti-murine B7-1, which does not precipitate any molecules because B7-1 is not expressed at this time point), or TM-1. The precipitates were analyzed using a 4-20 % gradient polyacrylamide gel under reducing (R) or nonreducing (N) conditions. The gel was autoradiographed on a phosphoimager, and the image obtained was processed and developed using the Photoshop program this directly, we analyzed the CD40L-mediated induction of costimulatory activity and that of known costimulatory molecules. Our results show that the induction of costimulatory activity precedes that of B7-1 and B7-2 -the induction of the costimulatory activity could be detected within 3 hours of CD40L-engagement, but no induction of B7-2 could be detected before 12 hours of culture. Such a disparity was not due to a lower sensitivity in the detection of B7-2 by FACS, because B7-2 could be detected on unstimulated spleen B cells (which have no detectable costimulatory activity in our assay). Using T cells from CD28-deficient mice, we also show that the CD40L-induced costimulatory molecules are independent of CD28, thereby precluding the possibility that another unidentified B7 family member, such as B7-3 [37] , could be involved.
CD40L therefore induces a costimulatory molecule(s) that is distinct from B7-1, B7-2 and HSA. We have produced a novel monoclonal antibody which binds an 85 kDa molecule that is involved in CD40L-induced costimulatory activity. Immunochemical studies and flow-cytometry analysis revealed that the monoclonal antibody does not bind to B7-1, B7-2, HSA, ICAM-1, ICAM-2, ICAM-3, CD40, CD40L or 4-1BB ligand. That CD40L-induced B cells can costimulate CD28-deficient T cells indicates that this novel costimulatory activity functions in a CD28-independent fashion. Our study may therefore explain the relatively mild immunodeficiency of the CD28-deficient mice. Although it has been suggested that immune responses in the CD28-deficient mice may represent costimulation-independent T-cell responses [35] , our study suggests that an alternative costimulatory pathway plays a major role in T-cell responses in vivo.
Conclusions
This study demonstrates unequivocally a role for the CD40L-CD40 interaction in T-cell-mediated induction of costimulatory activity on B cells. Furthermore, novel costimulatory molecules are likely to be involved in this process. We conclude that the CD40-CD40L interaction plays a central role in the reciprocal interactions between T and B cells, which result in their mutual activation (see Fig. 8 ). Certain viral infections [33] and certain immunoglobulin-antigen interactions [17] have been shown directly to induce B7-2 on B cells; under these conditions, the reciprocal conversation between T and B cells may therefore occur in the absence of CD40L [5] . 
Materials and methods
Experimental animals
The generation and breeding of the CD40L-deficient mice and their wild-type littermates have been fully described [29] . Mice with a targeted mutation of the CD28 gene, as described previously [38] , have been back-crossed to C57BL/6j mice for six generations and were kindly provided by Tak Mak (University of Toronto, Ontario, Canada). Age-matched mice, 6-20 weeks old, were used for this study. C57BL/6.CD28 -/-, C57BL/6j and CBA/CaJ mice aackson Laboratories, Bar Harbor, Maine) were used as the source of CD4 T cells.
T-cell proliferation assay
CD4 T cells were purified from mouse spleens as described [39] 
Induction of costimulatory activity by anti-CD3-triggered T cells
The basic protocol for the induction of costimulatory activity on APCs by anti-CD3-triggered T cells has been fully described [33] . To determine whether the defects in induction of costimulatory activity were due to T cells or APCs, T cells purified from either CD40L-deficient mice or their wild-type littermates were mixed with T-depleted spleen cells from either strain of mice and stimulated with anti-CD3 mAb for 16 h, the T-depleted APCs were isolated, and their fixation-resistant costimulatory activity determined. To test the requirement for the cognate interaction between T cells and APCs, the T-cell-depleted spleen cells were separated from total spleen cells by a 0.2 lpm polycarbonate membrane, and anti-CD3 mAb added at 1:40 dilution. After 16 h of culture, APCs from both chambers were isolated, fixed with 0.1 % paraformaldehyde and their costimulatory activity determined by the T-cell proliferation assay.
Induction of costimulatory activity by CD40L-transfected fibroblasts
COS cells were transfected with the CD40L gene by the DEAE-Dextran method [15] and used 72 h after transfection. NIH 3T3 cell line p-2 were transfected with CD40L by lipofection. After selection with neomycin, cells that were stably expressing CD40L were obtained by three consecutive FACS sorts using the anti-CD40L mAb MR1 [27] . B cells were purified from CBA/CaJ mice using magnetic beads (Dynal) as has been described [34] . Using this method, the purity of B cells is more than 99 %, and contamination of macrophages and dendritic cells is not detectable [34] . B cells (5 x 106 ml-1) and confluent CD40L-transfectants were co-cultured for a given period of time. The viable APCs were used for analysis of induction of costimulatory molecules by flow cytometry or were fixed with 0.1 % paraformaldehyde and assayed for their fixation-resistant costimulatory activity.
Flow cytometric analysis of the cell-surface expression of the costimulatory molecules B7-1, B7-2, ICAM-1 and HSA
Spleen APCs (106 cells per well), activated by T cells, were incubated with anti-B7-1 mAb 3A12 [39] , anti-B7-2 mAb GL-I [41] or anti-HSA mAb 20C9 [15] (hybridoma supernatants used at saturating doses). The binding of GL-1 was detected with mouse anti-rat IgG (Accurate, New York, USA); the binding of 3A12 and 20C9 was detected with the FTC-labelled goat anti-hamster IgG (Caltag, Mountainview, California, USA).
CHO cells, stably transfected with the B7-1 or B7-2 gene as described [39, 42] , or COS cells transiently transfected with the ICAM-1 gene [43] , were stained with the novel mAb TM-1. Antibodies against B7-1 (3A12), B7-2 (GL-1) and ICAM-1 (YN1/1.7.4; [44] ) were used as positive controls.
Production of monoclonal antibodies against CD40L-induced costimulatory molecules
Armenian hamsters were immunized intraperitoneally with 107 B cells which had been stimulated by CD40L for 5 h. Two weeks later, the hamsters were boosted with the CD40L-activated B cells and, three days after boost, spleen cells from the hamsters were fused with myeloma Ag8.653. The hybridoma supernatants were screened for the inhibition of CD4 T-cell proliferation using fixed, CD40L-activated B cells as costimulatory cells. Positive clones were screened for their binding to resting versus CD40L-activated B cells. Clones that preferentially bound activated B cells were cloned a further three times. The mAb derived from stable clone TM-1 was used for this study.
